Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Infectious Disease Point of Care Diagnostics market report explains the definition, types, applications, major countries, and major players of the Infectious Disease Point of Care Diagnostics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Cardinal Health, Inc (Ohio, US)
Cepheid (California, US)
Trinity Biotech (Bray, Ireland)
Quidel Corporation (San Diego, US)
Abbott Laboratories (Illinois, US)
Thermo Fisher Scientific Inc (Massachusetts, US)
BD (Franklin Lakes, US)
Quest Diagnostics Incorporated (New Jersey, United States)
Hoffmann-La Roche Ltd (Basel, Switzerland)
Mesa Biotech (California, US)
bioMérieux SA (Marcy l'Etoile, France)
Bio-Rad Laboratories Inc (California, US)
By Type:
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
By End-User:
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Infectious Disease Point of Care Diagnostics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Infectious Disease Point of Care Diagnostics Outlook to 2028- Original Forecasts
-
2.2 Infectious Disease Point of Care Diagnostics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Infectious Disease Point of Care Diagnostics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Infectious Disease Point of Care Diagnostics Market- Recent Developments
-
6.1 Infectious Disease Point of Care Diagnostics Market News and Developments
-
6.2 Infectious Disease Point of Care Diagnostics Market Deals Landscape
7 Infectious Disease Point of Care Diagnostics Raw Materials and Cost Structure Analysis
-
7.1 Infectious Disease Point of Care Diagnostics Key Raw Materials
-
7.2 Infectious Disease Point of Care Diagnostics Price Trend of Key Raw Materials
-
7.3 Infectious Disease Point of Care Diagnostics Key Suppliers of Raw Materials
-
7.4 Infectious Disease Point of Care Diagnostics Market Concentration Rate of Raw Materials
-
7.5 Infectious Disease Point of Care Diagnostics Cost Structure Analysis
-
7.5.1 Infectious Disease Point of Care Diagnostics Raw Materials Analysis
-
7.5.2 Infectious Disease Point of Care Diagnostics Labor Cost Analysis
-
7.5.3 Infectious Disease Point of Care Diagnostics Manufacturing Expenses Analysis
8 Global Infectious Disease Point of Care Diagnostics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Infectious Disease Point of Care Diagnostics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Infectious Disease Point of Care Diagnostics Export by Region (Top 10 Countries) (2017-2028)
9 Global Infectious Disease Point of Care Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Infectious Disease Point of Care Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Over-the-counter (OTC) Testing Kits Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prescription-based Testing Kits Consumption and Growth Rate (2017-2022)
-
9.2 Global Infectious Disease Point of Care Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Bacterial Infections Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Fungal Infection Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Virus Infection Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Infection Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Gastrointestinal Infection Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Sexually Transmitted Disease (STD) Infection Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Central Nervous System Infection Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Infectious Disease Point of Care Diagnostics Market Analysis and Outlook till 2022
-
10.1 Global Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.2.2 Canada Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.2.3 Mexico Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.2 UK Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.3 Spain Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.4 Belgium Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.5 France Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.6 Italy Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.7 Denmark Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.8 Finland Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.9 Norway Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.10 Sweden Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.11 Poland Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.12 Russia Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.3.13 Turkey Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.2 Japan Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.3 India Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.4 South Korea Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.5 Pakistan Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.6 Bangladesh Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.7 Indonesia Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.8 Thailand Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.9 Singapore Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.10 Malaysia Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.11 Philippines Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.4.12 Vietnam Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.5.2 Colombia Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.5.3 Chile Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.5.4 Argentina Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.5.5 Venezuela Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.5.6 Peru Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.5.7 Puerto Rico Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.5.8 Ecuador Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.6.2 Kuwait Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.6.3 Oman Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.6.4 Qatar Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.7.2 South Africa Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.7.3 Egypt Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.7.4 Algeria Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
-
10.8.2 New Zealand Infectious Disease Point of Care Diagnostics Consumption (2017-2022)
11 Global Infectious Disease Point of Care Diagnostics Competitive Analysis
-
11.1 Cardinal Health, Inc (Ohio, US)
-
11.1.1 Cardinal Health, Inc (Ohio, US) Company Details
-
11.1.2 Cardinal Health, Inc (Ohio, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Cardinal Health, Inc (Ohio, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.1.4 Cardinal Health, Inc (Ohio, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Cepheid (California, US)
-
11.2.1 Cepheid (California, US) Company Details
-
11.2.2 Cepheid (California, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Cepheid (California, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.2.4 Cepheid (California, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Trinity Biotech (Bray, Ireland)
-
11.3.1 Trinity Biotech (Bray, Ireland) Company Details
-
11.3.2 Trinity Biotech (Bray, Ireland) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Trinity Biotech (Bray, Ireland) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.3.4 Trinity Biotech (Bray, Ireland) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Quidel Corporation (San Diego, US)
-
11.4.1 Quidel Corporation (San Diego, US) Company Details
-
11.4.2 Quidel Corporation (San Diego, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Quidel Corporation (San Diego, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.4.4 Quidel Corporation (San Diego, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Abbott Laboratories (Illinois, US)
-
11.5.1 Abbott Laboratories (Illinois, US) Company Details
-
11.5.2 Abbott Laboratories (Illinois, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Abbott Laboratories (Illinois, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.5.4 Abbott Laboratories (Illinois, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Thermo Fisher Scientific Inc (Massachusetts, US)
-
11.6.1 Thermo Fisher Scientific Inc (Massachusetts, US) Company Details
-
11.6.2 Thermo Fisher Scientific Inc (Massachusetts, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Thermo Fisher Scientific Inc (Massachusetts, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.6.4 Thermo Fisher Scientific Inc (Massachusetts, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 BD (Franklin Lakes, US)
-
11.7.1 BD (Franklin Lakes, US) Company Details
-
11.7.2 BD (Franklin Lakes, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 BD (Franklin Lakes, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.7.4 BD (Franklin Lakes, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Quest Diagnostics Incorporated (New Jersey, United States)
-
11.8.1 Quest Diagnostics Incorporated (New Jersey, United States) Company Details
-
11.8.2 Quest Diagnostics Incorporated (New Jersey, United States) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Quest Diagnostics Incorporated (New Jersey, United States) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.8.4 Quest Diagnostics Incorporated (New Jersey, United States) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Hoffmann-La Roche Ltd (Basel, Switzerland)
-
11.9.1 Hoffmann-La Roche Ltd (Basel, Switzerland) Company Details
-
11.9.2 Hoffmann-La Roche Ltd (Basel, Switzerland) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Hoffmann-La Roche Ltd (Basel, Switzerland) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.9.4 Hoffmann-La Roche Ltd (Basel, Switzerland) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Mesa Biotech (California, US)
-
11.10.1 Mesa Biotech (California, US) Company Details
-
11.10.2 Mesa Biotech (California, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Mesa Biotech (California, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.10.4 Mesa Biotech (California, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 bioMérieux SA (Marcy l'Etoile, France)
-
11.11.1 bioMérieux SA (Marcy l'Etoile, France) Company Details
-
11.11.2 bioMérieux SA (Marcy l'Etoile, France) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 bioMérieux SA (Marcy l'Etoile, France) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.11.4 bioMérieux SA (Marcy l'Etoile, France) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Bio-Rad Laboratories Inc (California, US)
-
11.12.1 Bio-Rad Laboratories Inc (California, US) Company Details
-
11.12.2 Bio-Rad Laboratories Inc (California, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Bio-Rad Laboratories Inc (California, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
11.12.4 Bio-Rad Laboratories Inc (California, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Infectious Disease Point of Care Diagnostics Market Outlook by Types and Applications to 2028
-
12.1 Global Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Over-the-counter (OTC) Testing Kits Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Prescription-based Testing Kits Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Bacterial Infections Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Fungal Infection Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Virus Infection Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Cardiovascular Infection Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Gastrointestinal Infection Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Sexually Transmitted Disease (STD) Infection Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Central Nervous System Infection Consumption Forecast and Growth Rate (2022-2028)
-
12.2.8 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Infectious Disease Point of Care Diagnostics Market Analysis and Outlook to 2028
-
13.1 Global Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.2.2 Canada Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.2 UK Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.3 Spain Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.5 France Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.6 Italy Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.8 Finland Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.9 Norway Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.11 Poland Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.12 Russia Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.2 Japan Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.3 India Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.5.3 Chile Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.5.6 Peru Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.6.3 Oman Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Infectious Disease Point of Care Diagnostics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Infectious Disease Point of Care Diagnostics
-
Figure of Infectious Disease Point of Care Diagnostics Picture
-
Table Global Infectious Disease Point of Care Diagnostics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Infectious Disease Point of Care Diagnostics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Over-the-counter (OTC) Testing Kits Consumption and Growth Rate (2017-2022)
-
Figure Global Prescription-based Testing Kits Consumption and Growth Rate (2017-2022)
-
Figure Global Bacterial Infections Consumption and Growth Rate (2017-2022)
-
Figure Global Fungal Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Virus Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Sexually Transmitted Disease (STD) Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Point of Care Diagnostics Consumption by Country (2017-2022)
-
Table North America Infectious Disease Point of Care Diagnostics Consumption by Country (2017-2022)
-
Figure United States Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Canada Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Infectious Disease Point of Care Diagnostics Consumption by Country (2017-2022)
-
Figure Germany Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure UK Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Spain Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure France Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Italy Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Finland Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Norway Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Poland Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Russia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Table APAC Infectious Disease Point of Care Diagnostics Consumption by Country (2017-2022)
-
Figure China Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Table South America Infectious Disease Point of Care Diagnostics Consumption by Country (2017-2022)
-
Figure Brazil Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Chile Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Peru Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Table GCC Infectious Disease Point of Care Diagnostics Consumption by Country (2017-2022)
-
Figure Bahrain Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Oman Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Africa Infectious Disease Point of Care Diagnostics Consumption by Country (2017-2022)
-
Figure Nigeria Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Oceania Infectious Disease Point of Care Diagnostics Consumption by Country (2017-2022)
-
Figure Australia Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Infectious Disease Point of Care Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Cardinal Health, Inc (Ohio, US) Company Details
-
Table Cardinal Health, Inc (Ohio, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardinal Health, Inc (Ohio, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Cardinal Health, Inc (Ohio, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Cepheid (California, US) Company Details
-
Table Cepheid (California, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cepheid (California, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Cepheid (California, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Trinity Biotech (Bray, Ireland) Company Details
-
Table Trinity Biotech (Bray, Ireland) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trinity Biotech (Bray, Ireland) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Trinity Biotech (Bray, Ireland) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Quidel Corporation (San Diego, US) Company Details
-
Table Quidel Corporation (San Diego, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quidel Corporation (San Diego, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Quidel Corporation (San Diego, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Abbott Laboratories (Illinois, US) Company Details
-
Table Abbott Laboratories (Illinois, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories (Illinois, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Abbott Laboratories (Illinois, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Thermo Fisher Scientific Inc (Massachusetts, US) Company Details
-
Table Thermo Fisher Scientific Inc (Massachusetts, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Inc (Massachusetts, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Thermo Fisher Scientific Inc (Massachusetts, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table BD (Franklin Lakes, US) Company Details
-
Table BD (Franklin Lakes, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BD (Franklin Lakes, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table BD (Franklin Lakes, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Quest Diagnostics Incorporated (New Jersey, United States) Company Details
-
Table Quest Diagnostics Incorporated (New Jersey, United States) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Incorporated (New Jersey, United States) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Quest Diagnostics Incorporated (New Jersey, United States) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Hoffmann-La Roche Ltd (Basel, Switzerland) Company Details
-
Table Hoffmann-La Roche Ltd (Basel, Switzerland) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Ltd (Basel, Switzerland) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Hoffmann-La Roche Ltd (Basel, Switzerland) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Mesa Biotech (California, US) Company Details
-
Table Mesa Biotech (California, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mesa Biotech (California, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Mesa Biotech (California, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table bioMérieux SA (Marcy l'Etoile, France) Company Details
-
Table bioMérieux SA (Marcy l'Etoile, France) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table bioMérieux SA (Marcy l'Etoile, France) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table bioMérieux SA (Marcy l'Etoile, France) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Table Bio-Rad Laboratories Inc (California, US) Company Details
-
Table Bio-Rad Laboratories Inc (California, US) Infectious Disease Point of Care Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories Inc (California, US) Infectious Disease Point of Care Diagnostics Main Business and Markets Served
-
Table Bio-Rad Laboratories Inc (California, US) Infectious Disease Point of Care Diagnostics Product Portfolio
-
Figure Global Over-the-counter (OTC) Testing Kits Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prescription-based Testing Kits Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bacterial Infections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fungal Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Virus Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sexually Transmitted Disease (STD) Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Point of Care Diagnostics Consumption Forecast by Country (2022-2028)
-
Table North America Infectious Disease Point of Care Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Infectious Disease Point of Care Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Germany Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Infectious Disease Point of Care Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure China Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Infectious Disease Point of Care Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Infectious Disease Point of Care Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Infectious Disease Point of Care Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Infectious Disease Point of Care Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Australia Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Infectious Disease Point of Care Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
